Location History:
- Muenster, DE (2016)
- Havixbeck, DE (2015 - 2019)
Company Filing History:
1 out of 2,080 
1 out of 1 
1 out of 19 Years Active: 2015-2019
Title: Innovations of Inventor Michael Schaefers
Introduction
Michael Schaefers is an accomplished inventor based in Havixbeck, Germany, known for his significant contributions to medical technologies through his innovative patents. With a total of three patents to his name, Schaefers has focused his research on compounds that enhance diagnostic techniques for inflammatory diseases.
Latest Patents
Among his latest patents, one notable invention is related to quinoline-3-carboxamide compounds and their application in the diagnosis of inflammatory diseases. This patent outlines the use of these compounds, which are covalently linked to a label for imaging and detecting accumulation of S100A9 in inflammatory sites. The innovation allows for non-invasive molecular imaging techniques to evaluate the risk of developing such diseases and to monitor their progression.
Another vital patent pertains to ligands targeting S1P receptors for in vivo imaging and treatment of diseases. This invention includes novel compounds effective in the prevention, diagnosis, and treatment of disorders associated with sphingosine-1-phosphate (S1P). These disorders may include inflammation, pain, autoimmune diseases, and cardiovascular conditions.
Career Highlights
Throughout his career, Michael Schaefers has made a remarkable impact in the healthcare sector, working with prominent organizations such as Siemens Medical Solutions USA, Inc. and Westfälische Wilhelms-Universität Münster. His experience in these institutions has been pivotal in shaping his research and patent endeavors.
Collaborations
Schaefers has collaborated with esteemed colleagues in his field, including Guenter Haufe and Sven Hermann. These partnerships have fostered a productive exchange of ideas, leading to enhanced innovations in diagnostic methodologies and therapeutic applications.
Conclusion
In summary, Michael Schaefers is a distinguished inventor whose work is at the forefront of medical diagnostics. His patents on quinoline-3-carboxamide compounds and S1P receptor ligands highlight his commitment to developing solutions for the detection and treatment of inflammatory diseases. As his career progresses, Schaefers continues to contribute meaningfully to the future of healthcare innovations.